If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?

If Pfizer's Vaccine Is a Winner, Why Did This Analyst Downgrade Its Stock?
·2 min read

Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.